Tag: robust

Takeda oncology pipeline remains robust despite shift in focus from CAR-T to allogeneic cell therapies, says GlobalData – Medical Devices News
Head and Neck Healthcare

Takeda oncology pipeline remains robust despite shift in focus from CAR-T to allogeneic cell therapies, says GlobalData – Medical Devices News

February 29, 2024
admin

Takeda has decided to discontinue the development programs of its four oncology assets—Phase III asset modakafusp…

Continue Reading